drugset / Trial / NCT02104843
Drug Interaction Between Daclatasvir/Asunaprevir/BMS-791325 and Rosuvastatin
NaSingle-groupOpen-label
Summary
The primary purpose is to assess the effect of Daclatasvir (DCV)/Asunaprevir (ASV)/BMS-791325 combination therapy on the exposure of Rosuvastatin.
Timeline
- Start
- 2014-04
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asunaprevir | Small molecule | — | Oral |
| Subject | Beclabuvir | Small molecule | — | Oral |
| Subject | Daclatasvir | Small molecule | — | Oral |
| Subject | Rosuvastatin | Small molecule | — | Oral |